Johnson & Johnson (JNJ): Sen. Tommy Tuberville disclosed a sale $1K–$15K
Sen. Tommy Tuberville disclosed a sale of Johnson & Johnson in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 116 days
- Disclosure lag
- Traded
- Mar 29, 2021
- Disclosed
- Jul 23, 2021
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 14, 2020CongressDisclosed sale of JNJ — reported range $50,001 - $100,000
- Apr 16, 2020CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
- Jan 4, 2021CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
- Jan 15, 2021CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Jan 26, 2021CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
- Feb 16, 2021CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
- Feb 24, 2021CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Feb 25, 2021CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Mar 1, 2021FDARecall: Automated Impella Controller (AIC), Product No. 0042-0000-US, 0042-0010-US, 0042-0040-US. Used with Impella Ventricular Support Systems (cardiovascular)
- Mar 4, 2021CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Mar 26, 2021CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
- Mar 29, 2021 · this disclosureCongressDisclosed sale of JNJ — reported range $1,001 - $15,000
What came next
- Apr 13, 2021CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
- Apr 23, 2021CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
- Apr 30, 2021Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
- May 4, 2021CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
- Jun 25, 2021CongressDisclosed purchase of JNJ — reported range $250,001 - $500,000
- Jul 6, 2021CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Johnson & Johnson
For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.
Other recent filings by Sen. Tommy Tuberville
- Senate eFD periodic transaction report at Alphabet (GOOGL)Aug 5, 2026
- Senate eFD periodic transaction report at Goldman Sachs (GS)Aug 5, 2026
- Senate eFD periodic transaction report at Mastercard (MA)Aug 5, 2026
- Senate eFD periodic transaction report at Apple (AAPL)Aug 5, 2026
- Senate eFD periodic transaction report at Apple (AAPL)Aug 5, 2026
The full history of Sen. Tommy Tuberville is on the profile page.
How this filing works
Explore the data
Other disclosures at Johnson & Johnson
- House Clerk periodic transaction reportOct 5, 2026
- USAspending.gov award recordOct 5, 2026
- USAspending.gov award recordSep 24, 2026
- USAspending.gov award recordSep 22, 2026
- USAspending.gov award recordSep 21, 2026
- House Clerk periodic transaction reportSep 12, 2026
Everything OQRO holds on this company is on its JNJ page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
